PAIN THERAPEUTICS INC's ticker is PTIE and the CUSIP is 69562K100. A total of 69 filers reported holding PAIN THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $4,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
| Q4 2014 | $4,000 | -50.0% | 2,000 | 0.0% | 0.00% | – |
| Q3 2014 | $8,000 | -68.0% | 2,000 | -54.5% | 0.00% | – |
| Q2 2014 | $25,000 | +733.3% | 4,400 | +666.6% | 0.00% | – |
| Q1 2014 | $3,000 | 0.0% | 574 | 0.0% | 0.00% | – |
| Q4 2013 | $3,000 | +50.0% | 574 | 0.0% | 0.00% | – |
| Q3 2013 | $2,000 | -94.7% | 574 | -96.7% | 0.00% | – |
| Q2 2013 | $38,000 | – | 17,398 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,797,689 | $13,597,000 | 9.60% |
| SOPHROSYNE CAPITAL LLC | 1,265,020 | $6,147,000 | 5.38% |
| Madison Street Partners, LLC | 976,653 | $4,747,000 | 4.46% |
| INTREPID CAPITAL MANAGEMENT INC /DE/ | 460,000 | $2,236,000 | 2.28% |
| Broadfin Capital, LLC | 1,230,000 | $5,978,000 | 0.79% |
| 683 Capital Management, LLC | 427,071 | $2,076,000 | 0.59% |
| AVALON CAPITAL MANAGEMENT | 138,520 | $673,000 | 0.57% |
| Cheyne Capital Management (UK) LLP | 92,700 | $451,000 | 0.49% |
| Visium Asset Management, LP | 4,350,000 | $21,141,000 | 0.42% |
| Gruss Capital Management LP | 789,811 | $3,838,000 | 0.29% |